Historical shareholding details of DFA US Targeted Value Portfolio holdings in Oramed Pharmaceuticals, Inc (ORMP)

Monthly changes of DFA US Targeted Value Portfolio shareholding in Oramed Pharmaceuticals, Inc over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Dfa Us Targeted Value Portfolio 13,879 0.03%
Dec 31, 2024 Dfa Us Targeted Value Portfolio 13,879 0.03%
Nov 30, 2024 Dfa Us Targeted Value Portfolio 7,512 0.02%
Oct 31, 2024 Dfa Us Targeted Value Portfolio 7,512 0.02%
Sep 30, 2024 Dfa Us Targeted Value Portfolio 7,512 0.02%
Aug 31, 2024 Dfa Us Targeted Value Portfolio 7,512 0.02%
Jul 31, 2024 Dfa Us Targeted Value Portfolio 7,512 0.02%
Jun 30, 2024 Dfa Us Targeted Value Portfolio 7,512 0.02%
May 31, 2024 Dfa Us Targeted Value Portfolio 7,512 0.02%
Nov 30, 2023 Dfa Us Targeted Value Portfolio 0 0.00%
Sep 30, 2023 Dfa Us Targeted Value Portfolio 25,747 0.06%
Jul 31, 2023 Dfa Us Targeted Value Portfolio 25,747 0.06%

View all ownership details of Oramed Pharmaceuticals, Inc